Search

Search Constraints

You searched for: Author/Creator Pavel, Ana B.

Search Results

2. An integrated scalp and blood biomarker approach suggests the systemic nature of alopecia areata. Issue 10 (17th June 2021)

3. Analysis of alopecia areata surveys suggests a threshold for improved patient‐reported outcomes. (1st October 2022)

4. Analysis of alopecia areata surveys suggests a threshold for improved patient‐reported outcomes. (6th July 2022)

5. Delayed type hypersensitivity reactions to various allergens may differently model inflammatory skin diseases. Issue 1 (8th October 2022)

6. High‐dimensional analysis defines multicytokine T‐cell subsets and supports a role for IL‐21 in atopic dermatitis. Issue 10 (25th April 2021)

7. Phase 2a randomized clinical trial of dupilumab (anti‐IL‐4Rα) for alopecia areata patients. Issue 3 (6th September 2021)

9. Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata. Issue 4 (5th November 2022)